Has Amanda Armas received payments from drug or device companies?

Yes. Drug and device makers reported $2,852 in general payments to Amanda Armas across 148 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amanda Armas did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amanda Armas come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amanda Armas

Family · Tupelo, MSNPI 1184458663

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations.

$2,852in general payments, 2019–2025

Across 148 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Xeris Pharmaceuticals, Inc.$343
Sequel Med Tech, LLC$308
Medtronic$264
Corcept Therapeutics$260
Lilly USA, LLC$228
Insulet Corporation$228
plus $1K from 22 others

What the payments were for

Food & beverage$2,852100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Xeris Pharmaceuticals, Inc.	16	$343
Sequel Med Tech, LLC	9	$308
Medtronic	13	$264
Corcept Therapeutics	14	$260
Lilly USA, LLC	14	$228
Insulet Corporation	10	$228
Novo Nordisk	14	$182
Amgen	11	$158
Recordati_rare_diseases_inc.	8	$140
AbbVie	8	$112
RGH Enterprises LLC	2	$78
Boehringer Ingelheim	4	$65
Kyowa Kirin, Inc.	3	$52
Sanofi	2	$47
Dexcom, Inc.	2	$43
Soleno Therapeutics, Inc.	2	$38
Tandem Diabetes Care, Inc.	2	$36
Ionis Pharmaceuticals, Inc.	2	$35
AstraZeneca	1	$34
Alnylam Pharmaceuticals Inc.	2	$34
Acella Pharmaceuticals, LLC	2	$33
Neurocrine Biosciences, Inc.	1	$29
Antares Pharma, Inc.	1	$24
Madrigal Pharmaceuticals	1	$20
Ascensia Diabetes Care US Inc.	1	$17
Cequr Corporation	1	$15
GSK	1	$14
Bayer	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TWIIST$112

How this compares

$2,852 in reported general payments places this provider in the 85th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi →

Other family in Tupelo

Jessica EatonTupelo$25K
Lisa SandersTupelo$16K
Amanda RobinsonTupelo$15K
Ashley HensonTupelo$12K
Dodie McGeeRaymond$772K
Gina BurgeJackson$237K
Christy DavisJackson$208K
Maranda EversollFlowood$197K
Dana DelaskiJackson$158K
Kristin CarrollJackson$158K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →